MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
about
MicroRNA-155 and Its Role in Malignant HematopoiesisMicroRNAs in B-cells: from normal differentiation to treatment of malignanciesA 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.MiR-375 is Essential for Human Spinal Motor Neuron Development and May Be Involved in Motor Neuron Degeneration.MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.MiR-1188 at the imprinted Dlk1-Dio3 domain acts as a tumor suppressor in hepatoma cells.The pathological role and prognostic impact of miR-181 in acute myeloid leukemiaHigh expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.Epigenetic control of phospholipase A2 receptor expression in mammary cancer cellsPML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?Digging deep into "dirty" drugs - modulation of the methylation machinery.Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia.Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemiaThe Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription.miRNAs in acute myeloid leukemia.c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.microRNAs in Cerebrovascular Disease.Characterization of mouse serum exosomal small RNA content: The origins and their roles in modulating inflammatory response.Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2.MicroRNA: an important regulator in acute myeloid leukemia.MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis.AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB.Distinct miRNA profiles in normal and gastric cancer myofibroblasts and significance in Wnt signaling.An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.microRNA-451-modulated hnRNP A1 takes a part in granulocytic differentiation regulation and acute myeloid leukemia.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.miR-181c protects CsA-induced renal damage and fibrosis through inhibiting EMT.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells.The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.Modulation of miRNAs by Vitamin C in Human Bone Marrow Stromal Cells.MicroRNA-181 inhibits proliferation and promotes apoptosis of chondrocytes in osteoarthritis by targeting PTEN.
P2860
Q26777530-8BF1F282-E276-43B5-9ED1-001944B25F3AQ26824682-F07A7809-5865-4BA5-B2DE-32D015D85CA9Q33889001-57AF6ADA-D1E8-445E-A674-894D43535FE9Q34499599-24D8E450-6083-4605-9DC3-0D31DB300AC2Q34545956-4E3F2F08-BC0A-4622-BEE7-C3496D450137Q35390062-596C2286-D297-4E52-B53C-1B55E6441841Q35738628-6A6F31F5-BB75-4BFC-BB83-82AE37F792BDQ35741669-90422EAC-F4CD-485E-9254-DCEA87379A2CQ35808066-FCFEC56C-B712-48EA-AA04-8F65DAD59BFCQ35870127-F870753A-C6A9-479F-A079-41D04855132FQ35958274-0DB08991-013E-45CA-A5A9-9FF18AEEDE15Q36129863-B6C0AD38-4EAB-40BB-ABA0-2C5E21341B63Q36247415-518E4996-9EBC-4C1D-9D6D-A5BF437F968DQ36523796-32D3AA9C-FF83-485E-8AAD-7997D6E8B725Q36835382-D17E8774-492F-4020-8B68-F7238EEF4DAEQ36992190-ABFA9C9A-8701-47DD-BCCE-D3463C0B872FQ37288474-C566329F-49E2-4016-A700-926B07FD5124Q37336151-5670F645-5DCA-471A-A4C9-72B330810182Q37709531-687522F0-A379-4B71-BB0C-00D3EA7B697DQ37718379-51CB3D91-873A-4787-A555-23C575551158Q38668253-9CD51E31-1EF6-40DB-90EC-EBF7820E8948Q38682730-7E97327D-92E7-4EAF-B95B-B4F1EE4C8629Q38701636-868DCB79-076B-4685-905F-E831D36D2591Q38708780-816C0189-B3AB-4EC6-86FD-CC73F0527BD6Q38735859-6544DB06-AC0F-461B-8AD3-12B9BBE20AFBQ38815005-E5015261-7999-4716-BCAE-EC92E13B07DCQ38880958-167F507A-D962-48AA-BC3C-9DF5B33EF961Q38933683-58EB5215-8213-432C-8390-3ADB75BCDBFDQ39415910-5CF808B1-7305-4860-A561-1F38B589CA88Q39950263-09A1170C-A089-4EF7-A50A-22B7CEBC6A55Q41092512-4BCABB4D-30F5-4889-8EFF-63BDF59FAE82Q41548277-99D4196C-2B2D-4BBB-B66C-170F5E9D9FEFQ47100861-36FF61B0-612D-4293-88BB-1A97ADFB197AQ47701429-ABD73254-80C6-488A-8371-F29EBBCE79D8Q48104779-3331732E-3D51-40E5-83C2-2F64A9664314Q48880601-24217452-312A-472B-9302-E30048055CC2Q49305692-8501A646-A2FF-47C0-8CA8-90E90196A3BEQ49521797-7591EC99-5989-4B5E-B512-C6E924735909Q50117520-3B507129-126F-42BB-8E9C-3FC0F99FA2F2Q50904628-7B7B32CD-36A7-41EC-BBFD-FB3C2122F2F9
P2860
MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
MiR-181 family: regulators of ...... potential therapeutic targets.
@en
type
label
MiR-181 family: regulators of ...... potential therapeutic targets.
@en
prefLabel
MiR-181 family: regulators of ...... potential therapeutic targets.
@en
P2093
P2860
P356
P1433
P1476
MiR-181 family: regulators of ...... potential therapeutic targets.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.274
P407
P577
2014-09-01T00:00:00Z
P5875
P6179
1010535814